Hyperpolypharmacy and Frailty in Kidney Transplant Recipients
Authors:
Open Access
- 12 January 2022
- journal article
- research article
- Published by Elsevier in Transplantation Proceedings
- Vol. 54 (2) , 367-373
Abstract
No abstract availableKeywords
Funding Information
- Japan Society for the Promotion of Science (JP 90847394)
This publication has 28 references indexed in Scilit:
- Kidney Function and Prevalent and Incident FrailtyClinical Journal of the American Society of Nephrology, 2013
- Frailty and Early Hospital Readmission After Kidney TransplantationAmerican Journal of Transplantation, 2013
- Frailty Consensus: A Call to ActionJournal of the American Medical Directors Association, 2013
- Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin CNew England Journal of Medicine, 2012
- Influence of Pill Burden and Drug Cost on Renal Function After TransplantationPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2012
- Frailty and Delayed Graft Function in Kidney Transplant RecipientsArchives of Surgery, 2012
- Frailty and its association with disability and comorbidity in a community-dwelling sample of seniors in Montreal: a cross-sectional studyAging Clinical and Experimental Research, 2010
- Frailty and Chronic Kidney Disease: The Third National Health and Nutrition Evaluation SurveyThe American Journal of Medicine, 2009
- Significance of Frailty among Dialysis PatientsJournal of the American Society of Nephrology, 2007
- Comparison of Mortality in All Patients on Dialysis, Patients on Dialysis Awaiting Transplantation, and Recipients of a First Cadaveric TransplantNew England Journal of Medicine, 1999